Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.25 USD
66.67%
Updated:
May 17, 2024
Sonoma Pharmaceuticals Inc
Net Issuance of Debt
|
Sonoma Pharmaceuticals Inc
Net Issuance of Debt Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Net Issuance of Debt
$23k
|
CAGR 3-Years
-70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Issuance of Debt
-$11.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Issuance of Debt
$17.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Issuance of Debt
$35.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
52%
|
CAGR 10-Years
68%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Issuance of Debt
$3.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-7%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Issuance of Debt
$7.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is Sonoma Pharmaceuticals Inc's Net Issuance of Debt?
Net Issuance of Debt
23k
USD
23k
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Net Issuance of Debt amounts to 23k USD.
What is Sonoma Pharmaceuticals Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 3Y
-70%
-70%
The average annual Net Issuance of Debt growth rates for Sonoma Pharmaceuticals Inc have been -70% over the past three years .
You don't have any saved screeners yet
